Lehr Martin A. 4
4 · Context Therapeutics Inc. · Filed Mar 22, 2024
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-21+291,402→ 291,402 totalExercise: $1.07Exp: 2034-03-20→ Common Stock (291,402 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.